Kapitalforhøjelse i
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
May 22, 2024 04:07 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 22. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har forhøjet sin aktiekapital med nominelt DKK 187.020 som følge af medarbejderes udnyttelse af...
Capital Increase in
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
May 22, 2024 04:07 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company's share capital has been increased by nominally DKK 187,020 as a consequence of employees’ exercise...
Bavarian Nordic – tr
Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram samt ophør af aktietilbagekøbsprogram
May 21, 2024 17:25 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 21. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) meddeler, at aktietilbagekøbsprogrammet, der blev offentliggjort og iværksat den 8. maj 2024, nu er afsluttet, da det planlagte antal...
Bavarian Nordic – Tr
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
May 21, 2024 17:25 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced and initiated on May 8, 2024, has now been terminated, as the...
Laurence de Moerlooz
Laurence de Moerlooze fratræder som EVP og Chief Medical Officer i Bavarian Nordic
May 21, 2024 08:00 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 21. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at Laurence de Moerlooze har valgt at fratræde sin stilling som Executive Vice President og Chief Medical Officer i...
EVP and Chief Medica
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic
May 21, 2024 08:00 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 21, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that Laurence de Moerlooze will leave her position as Executive Vice President and Chief Medical Officer in the...
Bavarian Nordic lanc
Bavarian Nordic lancerer aktietilbagekøbsprogram til afdækning af incitamentsprogrammer
May 08, 2024 01:48 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet iværksætter et aktietilbagekøbsprogram, hvorunder selskabet vil tilbagekøbe op til 162.288 stk. egne...
Bavarian Nordic Laun
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations
May 08, 2024 01:48 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 8, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a new share buy-back program, under which the Company intends to buy back up to 162,288 of its own...
Bavarian Nordic offe
Bavarian Nordic offentliggør delårsregnskab for første kvartal 2024
May 08, 2024 01:37 ET | Bavarian Nordic A/S
KØBENHAVN, Danmark, 8. maj 2024 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab samt rapporterede på begivenheder for første kvartal 2024. Omsætningen i første kvartal udgjorde DKK...
Bavarian Nordic Anno
Bavarian Nordic Announces Interim Results for the First Three Months of 2024
May 08, 2024 01:37 ET | Bavarian Nordic A/S
COPENHAGEN, Denmark, May 8, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first three months of 2024. Revenue for the first...